CD8A and cutaneous mastocytosis: Treatment with mTOR inhibitor rapamycin increased survival, blocked breakdown of the blood–brain barrier and brain hemorrhaging, decreased the influx of both CD4(+) and CD8(+) T cells into the brain and the accumulation of parasitized red blood cells in a mouse model of cerebral malaria (CM), experimental CM [50].